AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN • US0017441017
20 USD
+0.52 (+2.67%)
Last: Mar 2, 2026, 01:00 PM
Taking everything into account, AMN scores 3 out of 10 in our fundamental rating. AMN was compared to 101 industry peers in the Health Care Providers & Services industry. AMN has a bad profitability rating. Also its financial health evaluation is rather negative. AMN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- AMN had positive earnings in the past year.
- AMN had a positive operating cash flow in the past year.
- In multiple years AMN reported negative net income over the last 5 years.
- AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- AMN has a Return On Assets of -4.57%. This is in the lower half of the industry: AMN underperforms 65.35% of its industry peers.
- AMN has a worse Return On Equity (-14.90%) than 61.39% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 1.73%, AMN is in line with its industry, outperforming 40.59% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for AMN is below the industry average of 9.08%.
- The 3 year average ROIC (6.19%) for AMN is well above the current ROIC(1.73%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -14.9% | ||
| ROIC | 1.73% |
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
1.3 Margins
- With a Operating Margin value of 1.21%, AMN perfoms like the industry average, outperforming 40.59% of the companies in the same industry.
- In the last couple of years the Operating Margin of AMN has declined.
- AMN has a Gross Margin of 28.35%. This is comparable to the rest of the industry: AMN outperforms 56.44% of its industry peers.
- AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.21% | ||
| PM (TTM) | N/A | ||
| GM | 28.35% |
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
2. Health
2.1 Basic Checks
- AMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for AMN has been increased compared to 1 year ago.
- AMN has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
- AMN has an Altman-Z score of 2.46. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of AMN (2.46) is comparable to the rest of the industry.
- The Debt to FCF ratio of AMN is 3.28, which is a good value as it means it would take AMN, 3.28 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of AMN (3.28) is better than 72.28% of its industry peers.
- A Debt/Equity ratio of 1.19 is on the high side and indicates that AMN has dependencies on debt financing.
- AMN's Debt to Equity ratio of 1.19 is on the low side compared to the rest of the industry. AMN is outperformed by 63.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.19 | ||
| Debt/FCF | 3.28 | ||
| Altman-Z | 2.46 |
ROIC/WACC0.23
WACC7.54%
2.3 Liquidity
- AMN has a Current Ratio of 0.94. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.94, AMN is not doing good in the industry: 72.28% of the companies in the same industry are doing better.
- A Quick Ratio of 0.94 indicates that AMN may have some problems paying its short term obligations.
- AMN has a worse Quick ratio (0.94) than 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
- The earnings per share for AMN have decreased strongly by -58.91% in the last year.
- AMN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.94% yearly.
- Looking at the last year, AMN shows a decrease in Revenue. The Revenue has decreased by -8.49% in the last year.
- The Revenue has been growing slightly by 2.67% on average over the past years.
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
3.2 Future
- The Earnings Per Share is expected to grow by 52.37% on average over the next years. This is a very strong growth
- AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.67% yearly.
EPS Next Y-49.83%
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
EPS Next 5Y52.37%
Revenue Next Year-5.63%
Revenue Next 2Y-0.9%
Revenue Next 3Y8.06%
Revenue Next 5Y7.67%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- AMN is valuated correctly with a Price/Earnings ratio of 14.71.
- Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 84.16% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.07, AMN is valued a bit cheaper.
- AMN is valuated quite expensively with a Price/Forward Earnings ratio of 29.31.
- The rest of the industry has a similar Price/Forward Earnings ratio as AMN.
- AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.71 | ||
| Fwd PE | 29.31 |
4.2 Price Multiples
- 80.20% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, AMN is valued cheaply inside the industry as 98.02% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.29 | ||
| EV/EBITDA | 7.81 |
4.3 Compensation for Growth
- AMN's earnings are expected to grow with 78.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
5. Dividend
5.1 Amount
- AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:AMN (3/2/2026, 1:00:52 PM)
20
+0.52 (+2.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19 2026-02-19/amc
Earnings (Next)05-06 2026-05-06/amc
Inst Owners109.44%
Inst Owner Change-1.1%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap768.20M
Revenue(TTM)2.73B
Net Income(TTM)-95.70M
Analysts69.23
Price Target22.66 (13.3%)
Short Float %5.11%
Short Ratio1.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.78%
Min EPS beat(2)-21.51%
Max EPS beat(2)93.07%
EPS beat(4)3
Avg EPS beat(4)60.31%
Min EPS beat(4)-21.51%
Max EPS beat(4)116.02%
EPS beat(8)7
Avg EPS beat(8)40.9%
EPS beat(12)11
Avg EPS beat(12)30.43%
EPS beat(16)15
Avg EPS beat(16)25.36%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.64%
Max Revenue beat(2)2.36%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)2.36%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)7
Avg Revenue beat(12)0.85%
Revenue beat(16)11
Avg Revenue beat(16)1.44%
PT rev (1m)8.74%
PT rev (3m)6.14%
EPS NQ rev (1m)658.24%
EPS NQ rev (3m)611.34%
EPS NY rev (1m)-7.6%
EPS NY rev (3m)-34.62%
Revenue NQ rev (1m)94.61%
Revenue NQ rev (3m)94.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.71 | ||
| Fwd PE | 29.31 | ||
| P/S | 0.28 | ||
| P/FCF | 3.29 | ||
| P/OCF | 2.85 | ||
| P/B | 1.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.81 |
EPS(TTM)1.36
EY6.8%
EPS(NY)0.68
Fwd EY3.41%
FCF(TTM)6.09
FCFY30.44%
OCF(TTM)7.02
OCFY35.08%
SpS71.09
BVpS16.72
TBVpS-10.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -14.9% | ||
| ROCE | 2.19% | ||
| ROIC | 1.73% | ||
| ROICexc | 1.77% | ||
| ROICexgc | 5.91% | ||
| OM | 1.21% | ||
| PM (TTM) | N/A | ||
| GM | 28.35% | ||
| FCFM | 8.56% |
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
ROICexc(3y)6.27%
ROICexc(5y)13.02%
ROICexgc(3y)21.12%
ROICexgc(5y)45.11%
ROCE(3y)7.84%
ROCE(5y)15.78%
ROICexgc growth 3Y-59.99%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-59.19%
ROICexc growth 5Y-26.95%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
F-Score5
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.19 | ||
| Debt/FCF | 3.28 | ||
| Debt/EBITDA | 4.04 | ||
| Cap/Depr | 22.75% | ||
| Cap/Sales | 1.3% | ||
| Interest Coverage | 0.74 | ||
| Cash Conversion | 141.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | 2.46 |
F-Score5
WACC7.54%
ROIC/WACC0.23
Cap/Depr(3y)44.93%
Cap/Depr(5y)49.12%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
EPS Next Y-49.83%
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
EPS Next 5Y52.37%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
Revenue Next Year-5.63%
Revenue Next 2Y-0.9%
Revenue Next 3Y8.06%
Revenue Next 5Y7.67%
EBIT growth 1Y-72.31%
EBIT growth 3Y-62.85%
EBIT growth 5Y-30.5%
EBIT Next Year219.97%
EBIT Next 3Y39.54%
EBIT Next 5YN/A
FCF growth 1Y-2.38%
FCF growth 3Y-25.82%
FCF growth 5Y1.44%
OCF growth 1Y-15.9%
OCF growth 3Y-25.58%
OCF growth 5Y0.97%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 3 / 10 to AMN.
Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 3 / 10.
What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?
The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -49.83% in the next year.